Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other ...
The City of Huntsville is proud to welcome Eli Lilly and Company (NYSE: LLY) to North Alabama! The global pharmaceutical leader announced plans to invest more than $6 billion in a next-generation manufacturing facility in Huntsville – the largest industrial private investment ever made in the State of Alabama. The advanced facility will be constructed on a 260-acre site at the northeast ...
Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...
HUNTSVILLE – Governor Kay Ivey on Tuesday announced pharmaceutical giant Eli Lilly and Company plans to invest more than $6 billion in a new advanced manufacturing operation in Huntsville, where it will produce next-generation medicines. The global pharmaceutical giant also will bring 450 jobs to the region, including engineers, scientists, operations personnel and lab technicians. The ...
Eli Lilly and Company delivered best-in-class weight loss data for retatrutide, reinforcing its dominance in obesity and diabetes therapeutics. Retatrutide achieved up to 28.7% average weight loss ...
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.